PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis
CONCLUSION: This primitive study shows multiparameter PSMA PET/MR to be useful in identifying glioma (especially GBM) recurrence by providing excellent tumor background comparison, tumor heterogeneity, recurrence prediction and prognosis information, although it did not improve the diagnostic performance compared to conventional MRI. Further and larger studies are required to define its potential clinical application in this setting.PMID:38214322 | DOI:10.2174/1574892818666230519150401
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Authors: Min Xiong Zhenghe Chen Chao Zhou Xiaochun Yang Wanming Hu Yongluo Jiang Rongliang Zheng Wei Fan Yonggao Mou Xiaoping Lin Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Germany Health | Glioma | MRI Scan | PET Scan | Study